Clinical Trial Update: Optimal Injection Interval for Intra-Detrusor Botulinum Toxin [NA]

View source ↗

Summary

Clinical trial update on the optimal intradetrusor botulinum toxin injection interval for overactive bladder conditions; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Urinary Incontinence
• Urinary Incontinence
• Urinary Urgency

Drugs mentioned

• Botulinum toxin (intradetrusor) (Botulinum toxin type A)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Overactive Bladder, Urinary Urgency | NA | Status: NOT_YET_RECRUITING